Additionally, metformin exerts regulatory effects on inflammation and fibrosis in DKD by targeting the tenascin-C (TNC)/TLR4/NF-κB/miRNAs inflammatory loop [225]. This evidence concerns the gene NFKB1 and diabetic kidney disease.